Treatments mostly aim to retrain the brain’s fear response. Many patients are given cognitive therapy, which teaches them to think differently about what happened and trains them to cope with triggers. Debra Kaysen of the University of Washington says severe symptoms recede in about four out of five patients following a dozen or so sessions. Other patients are given exposure therapy, in which they are confronted with the feared stimuli. Adults may be asked to describe a traumatic event in excruciating detail until it loses its potency; young children might play out what happened with toys. Virtual-reality simulations have been used on soldiers. One therapist compares the work to treating a burn victim: layer after layer.

Soon after her ordeal, Ms Hopper started cognitive therapy. The first aim was to get her back in her car. Her counsellor taught her to walk to it and replace intrusive thoughts (there could be someone hidden inside) with safe ones (I have parked here for years without problems). On around the tenth attempt, she managed to get back in. Conquering her fear of the dark took much longer, but eventually “one day my brain and body just caught up with my mind,” she says.

Most research on PTSD has focused on victims in rich countries, particularly America. But trauma happens everywhere. Dr Kaysen has adapted therapies developed in rich countries to survivors of torture in Iraq and rape in Congo. The results suggest that the disorder has the same characteristics in different locations and cultures, and also that similar treatments work—even in tough settings such as refugee camps.

New treatments are now being developed through animal experiments. One trial taught rats to fear a scent by spraying it at the same time as administering an electric shock; if it was sprayed repeatedly soon afterwards without a shock being administered, PTSD symptoms such as uncontrolled fear, measured by the animal’s “freezing” or heart-rate response, did not develop. Researchers then sought to find out whether there is a similar window of opportunity in humans who have experienced trauma. In a pilot programme in 2010, some patients who came into the emergency room at Grady Memorial Hospital in Atlanta following a rape, gunshot wound or car crash were given “imaginal exposure therapy”, in which they were asked to recall vividly what happened. Three months later, only half as many developed PTSD as in a comparable group that did not receive such therapy. Further trials will be needed to confirm that such early debriefings can help.

Recently Dr Ressler immobilised mice for two hours. They became more likely to develop PTSD-like symptomsafter future trauma. Autopsies of their brains showed a change in gene __EXPRESSION__ that the researchers think might have caused the vulnerability. In a follow-up trial an experimental drug was used to target this gene and block the formation of fearful memories. Encouragingly, mice that had previously gone through the ordeal and then received the drug did not develop symptoms of PTSD when exposed to another frightening situation.

Amit Etkin and colleagues at Stanford University are studying how the brain circuits that control fear can be tweaked with the aid of SSRIs (a class of drugs, some of which are used to treat depression or anxiety) and transcranial magnetic stimulation, in which an electromagnet held close to the scalp transmits magnetic pulses to the brain. They found that stimulating a part of the frontal lobe can reduce activity in the amygdalae, which could lessen the symptoms of PTSD. Within five years, thinks Dr Etkin, new therapies will be available, including applying brain stimulation or using drugs to enhance the effects of talk therapy. Better treatments for other anxiety disorders, which afflict a third of Americans, could follow.

Even if new treatments for PTSD take longer to develop than hoped, acceptance of PTSD’s inherently physical nature could encourage sufferers to seek help earlier. Rape victims in Dr Kaysen’s practice typically waited 20 years before turning to her; Dr Marmar has treated veterans of the second world war who had tried to cope with their nightmares for as long as 40 years.

In a freezer in Boston are 50 samples of brain tissue donated to the world’s first brain bank dedicated to the study of PTSD, set up by the Department of Veterans Affairs. More veterans and civilians, with and without the disorder, are filling in health questionnaires and pledging to donate brain tissue after death. Those who could not be healed themselves might help arm future generations against the same suffering, or perhaps, one day, help prevent it altogether.